Document 6529352

Latest innovations in
personalized medicine
Biobanking &
© Kirsty Pargeter - Fotolia.com
Sample
Management
From small scale collections to intelligent large scale biobanks
26th - 28th May 2009 | Steigenberger Airport Hotel, Frankfurt/Main, Germany
Meet 18 international top-level
companies and institutions:
Schering Pharma AG,
Germany
GlaxoSmithKline plc., USA
UK Biobank, UK
Wales Cancer Bank, UK
Biobank of the
Comprehensive Cancer Care
Center Bonn, Germany
Opinion Leader, UK
INSERM (National Institute
for Health and Medical
Research), France
Independent Centre for
Privacy Protection Schleswig Holstein (ULD), Germany
Perma Cryo Technologie GmbH, Germany
Fraunhofer Institute for
Biomedical Engineering
(IBMT), Germany
Biobank of the Medical
University of Graz, Austria
Genetic Interest Group, UK
 STARLIMS EUROPE, UK
University of Regensburg,
Germany
PATH - Patients Tumorbank
of Hope, Germany
Pasteur Institute, France
European Commission
F. Hoffmann-La Roche Ltd,
Switzerland
Bayer
4c Euroskala
PCT-Grün: C 100, M=0, Y=44, K=17
PCT-Grün Farbtöne: 100%, 65%, 30%
PCT-Grau: C=15, M=0, Y=10, K=45
Learn how to enhance sample collection and storage procedures to assure
sample quality and data integrity

Implement efficient IT systems for sample management in order to realize
the right IT solution for storing, locating and accessing your biomaterials

Hear how to enhance security and safety of a clinical biobank to realize
efficient biobank management for optimal future research

Explore how patients become involved in biobank projects as patients
advocates or advisers to make your biobank appear more reliable

Learn to create the ideal informed consent document to maximise the
potential usage of your samples
Highlights
Dr. Arndt Schmitz, Bayer Schering Pharma AG
Case study: Biobanking in pharma research to enable oncology
biomarker validation
Dr. Daniele Paci, European Commission - DG Joint Research Center
The economic impact of biobanks and biobanks networking in Europe
Ashley E. Hayes, F. Hoffmann-La Roche Ltd
Creating a non-clinical biorepository
Interactive workshop day
A
B
C
D
How to build a biobank
Building a non-clinical biorepository
Inter-operability, data and sample sharing and consent convenor
Biobanks and biomarkers
Media Partners
SA
V
if
y up
20 ou to
th bo 27
Fe ok 0 E
br b u
ua ef ro
ry ore s
20 th
09 e
!
E
Sponsors

To Register
T +49 (0)30 20 91 33 30 | F +49 (0)30 20 91 33 12 | E [email protected] | Visit www.iqpc.com/de/biobanking/MM
Biobanking &
Sample Management
26th - 28th May 2009, Steigenberger Airport Hotel, Frankfurt/Main, Germany
Dear Colleague,
Who will you meet?
increasing efforts in both academia and industry are being invested in the construction and optimisation of biobanks globally. Biobanks are becoming indispensable research tools. From
identification and validation of new targets and biomarkers to efforts in creating personalised
medicine, Biobanks play an important role in drug discovery and biological science.
While the importance of biobanks is widely recognized, the development of biobanks still faces
many ethical, legal, scientific, financial and information technology challenges.
How to find the ideal software solution, how to ensure sample quality and data integrity and
how to overcome biobank specific implementation problems of the informed consent concept –
That is why IQPC is dedicating its upcoming international congress on:
International pharmaceuticals and
biotech companies, independent
and national biobanks and tissue
banks, medical research institutes,
related government officials
Global Heads, Directors, Senior
Scientists, Researchers, Leaders
of the following departments:
Biobanking & Sample Management
From small scale collections to intelligent large scale biobanks

26th – 28th May 2009, Steigenberger Airport Hotel, Frankfurt/Main, Germany


Learn which impact different national regulations have on sharing samples across national

borders
Make donation more acceptable by using the right instruments to engage the general public
on issues such as tissue donation and biobanking
 Explore how to create a clear and flexible informed consent document to make donation
more acceptable and increase the number of sample donors




Biobanking
Biorepositories
Biomarker
(Biological) Sample Management
Pharmacogenomics
Personalized Medicine
Drug Discovery
Research & Developement
Experts from international companies and institutions such as Bayer Schering Pharma,
Hoffmann-La Roche, UK Biobank, European Commission, GlaxoSmithKline, Wales Cancer Bank
and many more will report about first-hand case studies and best practices.
For further information...
Save your place and book now! We are looking forward to meeting you in Frankfurt!
Kind regards
Your pharmaIQ Team
please contact Mark Reichmann on:
+49 (0) 30 20 91 34 28 or email
[email protected]
PS: Do not miss to hear latest case studies and discuss with representatives of pharmaceutical
industry, biobanks and academia the future of biobanking.
Don't Forget to Check our Team discounts
Groups of 3 or more bookings at the same time from the same
company: add another 5% per person on any Early Bird, 10% per
person on standard price. (Only for platinum/gold packages)
Media Partners
BIOforum Europe provides the European biotechnology and life science markets with the latest news and trends in research and development.
Main focuses are applied research, interviews, company profiles, Bio Business and Bio regions. www.bioforum-europe.com
SCREENING - Trends in Drug Discovery focuses new trends and developments in drug discovery. It covers all aspects of research as well as strategies
of pharmaceutical companies and start-ups. www.gitverlag.com
G.I.T. Laboratory Journal Europe reports on all important topics relevant for the European laboratory market. Latest developments in analytics, technology,
lab equipment, furniture and lab automation are displayed either in application notes from the chemical, food and pharmaceutical industry or in scientific
articles. Bimonthly, G.I.T. Laboratory Journal Europe reaches 27,000 personalised addresses in industrial R&D and scientific institutions throughout Europe.
www.gitverlag.com
www.PharmCast.com is the world leading website designed specifically for pharmaceutical, clinical and biotechnology professionals. www.PharmCast.com
brings up-to-date information on pharmaceutical patents, FDA, news, jobs and Buyer's Guide to our visitors. It was created and is maintained by pharmaceutical and biotechnology professionals. Visit www.PharmCast.com and discover for yourself why it is so popular among professionals.
www.pharmcast.com
PharmaVOICE is the executive forum that allows business leaders to engage in a candid dialogue on the myriad challenges and trends impacting the
life-sciences industry. PharmaVOICE reaches more than 17,000 U.S.-based executives who influence business strategies and affect change. Published
monthly, PharmaVOICE provides readers with insightful and thought-provoking commentary in a multiple-perspective format through its forums, topics,
and articles that cover a range of issues from molecule through market. www.pharmavoice.com
Scientific Computing World is Europe’s only publication dedicated to the computing and information technology needs of professionals working in science,
technology, engineering and medicine. Published in print and electronic media, it covers all aspects of computing, from the way in which the latest
software is revolutionising research to the practicalities of new product installations. In all media, Scientific Computing World reports and analyses the
application of computing to science, technology and medicine, focusing on engineering, design, research, development, testing, and laboratory analysis
(including QA/QC). The publications carry news, comment, feature articles, product news, and the website is particularly known for its authoritative software services. The annual Laboratory Informatics Guide is published with the December/January issue and highlights the very latest developments in lab
informatics software. In 2008, Scientific Computing World enters its 15th year of publication, underlining its position as a market-leading title in this key
sector. Published 6 times per year, it has an ABC audited circulation of 17,976 and so, with a pass on readership, it reaches around 80,000 readers.
www.scientific-computing.com
To Register
|
T +49 (0)30 20 91 33 30
|
F +49 (0)30 20 91 33 12
|
E [email protected]
|
Visit www.iqpc.com/de/biobanking/MM
Biobanking &
Sample Management
Congress Day one | Tuesday, 26th May 2009
8:30
Registration with coffee break & networking
12:25
Patient involvement in the Wales Cancer Bank
 The importance of patient involvement
 How patients became involved with the project as donors,
Case Study
patient advocates and advisers
 The impact of patients at Wales Cancer Bank
 Information about the donor profile
Dr. Alison Parry-Jones, Manager,
Wales Cancer Bank, UK
9:00
Chairman’s welcome & opening address
Dr. Ulrich Stockter, formerly
Independent Centre for Privacy Protection
Schleswig-Holstein (ULD), Germany
Current legal and economic aspects
The economic impact of biobanks and biobanks
networking in Europe
 European Commission JRC and IPTS: IPTS activities
Public
on biobanking
Authority
Insight
 The economics of biobanks
Biobanks as research infrastructures
Costs and benefits from networking
 The economic impact of biobanks and biobanks networking
Existing literature
Outline of a tentative study to determine and quantify
the economic impact
Methodology and expected results
 Conclusions and future developments
Dr. Daniele Paci, Institute for Prospective Technological
Studies,
European Commission - DG Joint Research Center
T
H
G
LI
H
IG
H
9:15
Elaborating and implementing biobanking guidelines
9:55
Roadmap for biobanking guidelines
 Best practices for Biobanks (OECD, IARC, NCI, ISBER,
French norm (NF S96-900)...)
Standardization
Insight
 Is it possible to reach consensual guidelines?
 Certification or accreditation for biobanks?
 Proof of concept for certification: The case of French
biobanks network
Georges Dagher, Clinical Research Facilities Mission,
INSERM (National Institute for Health and Medical
Research), France
10:35
Refreshment break & networking
Understanding bioethics and informed consent
11:05
Explore the public's attitude towards tissue donation
 How to analyze the public’s attitude towards biobanking
and tissue donation
Expert's
View
 Identify circumstances under which donation becomes
more acceptable or attractive
 Discuss issues pertaining to obtaining informed and
valid consent
 Outline processes used to engage the general public
on issues such as tissue donation and bio-banking
Katie Shearn, Researcher,
Opinion Leader Ltd., UK
11:45
Informed consent and biobanks
 Function and meaning of informed consent
Data
 Biobank specific implementation problems of the informed
Protection
consent concept
Insight
 Possible biobank specific adjustments of the informed
consent concept and their data protection related assessment
Research purpose specific agreement
Concept of the test person codetermination Procedural and material law instruments for the
adjustment of biobank specific deficits of the concept
of informed consent
Dr. Ulrich Stockter, formerly
Independent Centre for Privacy Protection
Schleswig-Holstein (ULD), Germany
13:05
Networking luncheon
Promoting data and benefit sharing
14:35
Implementation of UK Biobank
Managing huge amount of samples
 Setting up a feasible technical infrastructure
 Implementing sample and data collection strategies
Paul Downey, Director of Operations,
UK Biobank, UK

Expert's
View
Intelligent IT and software solutions for biobanking
15:15
Setting up and validating an IT system
Definition of the needs: Which key information must be
kept in the database?
IT
Insight
 Challenges and communication with a company:
Making sure we understand each other, keeping deadlines
 Utilisation of the system: Functionalities, validation process
 The future of the database: Evolution and implementation
of the system
Blandine Rimbault, Investigation Clinique et Accès aux
Ressources Biologiques, ICAReB,
Pasteur Institute, France

15:55
Refreshment break & networking
16:25
Where have all the samples gone… IT-Solution for local
sample and data management in the Pathology department
Software
 How to realize an intelligent IT-solution for local sample
Insight
and datamanagement
 Start small and grow – Experience at the Center for
Integrated Oncology Köln-Bonn Biobank
 Any fool can do it – Software requirements from the
pathologist point of view
 BiobankPro – Flexible and efficient sample and data
management solution
Dr. Lukas Heukamp, Pathologist,
Biobank of the Comprehensive Cancer Care Center
Bonn, Germany
17:05
Panel
Realizing an intelligent software solution for biobanks?
Discuss with speakers of the day how to create the most
feasible IT solution which perfectly meets the demands of
your biobank and is flexible enough to adjust to changing
sample collections.
 Working with a large amount of data
 Security aspects
 Quality management by efficient IT systems
Chaired by:
Dr. Lukas Heukamp, Pathologist,
Biobank of the Comprehensive Cancer Care Center
Bonn, Germany
Panelists:
Wayne H. Anderson, Ph.D., Head, Applied Genetics, Respiratory,
GlaxoSmithKline, USA
and speakers of the day
17:35
Final remarks of the chairman and end of congress day one
Discussion
Sponsorship
We have a variety of packages available to suit your requirements.
For all Sponsorship and Exhibition opportunities call our Sponsorship Team on: +49 (0) 30 20 91 32 75 or email [email protected]
To Register
|
T +49 (0)30 20 91 33 30
|
F +49 (0)30 20 91 33 12
|
E [email protected]
|
Visit www.iqpc.com/de/biobanking/MM
Biobanking &
Sample Management
Congress Day Two | Wednesday, 27th May 2009
8:30
Registration, coffee & networking
11:45
9:00
Chairman’s welcome
Dr. Arndt Schmitz, The Research Biobank,
Global Drug Discovery,
Bayer Schering Pharma AG, Germany
Biobanking in pharma research – Sample storage and access
How to realize the potential of translational
medicine? – Biobanking in pharma research to
enable oncology biomarker validation
 Characteristics of a pharma research biobank
 Ensuring sample quality and data integrity
 Access to human samples for pharma research –
Creating win-win for clinician and patient
 How to obtain healthy control samples
 Realizing synergies with own in house clinical studies
 Examples of oncology biomarker validation projects
and their sample requirements
Dr. Arndt Schmitz, The Research Biobank,
Global Drug Discovery,
Bayer Schering Pharma AG, Germany
12:25
Networking luncheon
14:05
New integrated cryotechnologies for cell banks: thetechnology of the "Global HIV Vaccine Research Cryorepository”
 Construction and aim of the global HIV vaccine research Expert's
network
View
 Access tower technology and cryoworkbench technology to maintain the temperature chain of a sample closed
 Storage of samples with their data to generate a 100% sample identification
 Management and documentation of the sample
processing and storage by a special LIMS
Prof. Dr. Heiko Zimmermann, Head of Division,
Fraunhofer Institute for Biomedical Engineering (IBMT),
Germany
The Emergence of the Biorepository Informatics Market
The Bio Repository Markets
 Clinical and Pharmaceutical
 Global Legislations
 Managing Consent
 Chemical Repositories
 Example Case Studies
 The Integration of LIMS and Repository Functionality
 Q & A
Joe Peden, General Manager,
STARLIMS EUROPE

Technology
Update
T
H
G
LI
H
IG
H
9:15
Case Study
9:55
A new scalable technology platform for liquid nitrogen
driven cryobanks based on electronically "flagged" samples
 Sample identification solutions (incl. RFID transponder) for Specialist’s
temperatures down to -196°C
insight
 Electronic screening of samples in closed freezer systems
 Laboratory workflow documentation and process control by smart samples
 Solutions for ice free motorised sample retrieval
 Case study: Global HIV Cryo Repository (Bill & Melinda Gates Foundation)
Benedikt Lehnert, Head of Marketing & Brandmanagement,
Perma Cryo Technologie GmbH
10:35
14:45
Example from real life: PATH Foundation's Tumorbank
Implementation and feasibility of an independent,
decentred tissue bank
Case
Study
 Informed consent - legal and ethical aspects from
patients point of view
 PATH-database - realization, scale and possibilities
 Follow-Up: Challenge and chance for a tumor bank
Tobias Anzeneder, Project Leader and Medic,
PATH - Patients Tumorbank of Hope, Germany
Refreshment break & networking

15:25
Refreshment break & networking
16:05
Creating a non-clinical biorepository
 Collecting, processing, storing and distributing
biological specimens
Case Study
 Experiences with the establishment of a centralized
repository
 Global application to share the available information
Ashley E. Hayes, Roche Non-Clinical Biorepository (RNCB),
F. Hoffmann-La Roche Ltd, Switzerland
T
H
G
LI
H
IG
H
11:05
Efficient biobank management for optimal future research
Realizing IT systems in clinical routine
Security and safety of a clinical biobank
From small scale collections to large scale institutional
biobank
 A case study of the Biobank of Medical University Graz
Dr. Karine Sargsyan, Director Biobank,
Medical University of Graz, Austria
Clinical
Insight



16:45
Final remarks of the chairman and end of congress day two.
4c Euroskala
PCT-Grün: C 100, M=0, Y=44, K=17
PCT-Grün Farbtöne: 100%, 65%, 30%
PCT-Grau: C=15, M=0, Y=10, K=45
Sponsors
Perma Cryo Technologie GmbH
Kaiserstraße 170-174
66386 St. Ingbert, Germany
Phone: +49 6894 103 - 201
Fax: +49 6894 103 - 208
Email: [email protected]
www.perma-cryo.com
STARLIMS Europe
Endeavour House,
98 Waters Meeting Road
Bolton, Lancs, BL1 8SW, UK
Phone: +44 (0) 1204 546 700
Fax: +44 (0) 1204 546 701
Email: [email protected]
www.starlims.com
To Register
|
HAMILTON AG
Via Crusch 8
CH-7402 Bonaduz, Switzerland
Phone: +49 89 552 649 15
Fax: +49 89 552 649 10
Email: [email protected]
www.hamiltonrobotics.com
Thermo Scientific
Unit 2 Lower Meadow Road,
Brooke Park
Handforth, Wilmslow, SK9 3LP
Phone: 0161 486 2112
Fax: 0870 609 9202
Email: [email protected]
www.thermofisher.com
T +49 (0)30 20 91 33 30
|
LabWare LIMS solutions
Denzell Lodge, Denzell Gardens, Altrincham
Cheshire, WA14 4QE, UK
Phone: +44 (0) 8700 115585
Fax: +44 (0) 8700 114516
Email: [email protected]
www.labware.com
Nexus Biosystems GmbH
Alpenstr. 76
82538 Geretsried, Germany
Phone: +49-6485-1830670
Fax: +49-6485-1830671
Email: [email protected]
www.nexusbio.com
F +49 (0)30 20 91 33 12
|
Lab Services BV
Postbox 4697
4803 ER, The Netherlands
Phone: +31765310420
Fax: +31765310421
Email: [email protected]
www.lab-services.nl
Fraunhofer Institute for Biomedical
Engineering (IBMT)
Ensheimer Strasse 48
66386 St. Ingbert, Germany
Phone: +49/6894/980-257
Fax: +49/6894/980-400
Email: [email protected]
www.ibmt.fraunhofer.de
E [email protected]
|
Globex Couriers GmbH
Bunsenstrasse 5
64347 Griesheim, Germany
Phone: +49 6155 824 514
Fax: +49 6155 824 233
www.globex24.com
Visit www.iqpc.com/de/biobanking/MM
Biobanking &
Sample Management
Interactive Workshop day | Thursday, 28th May 2009
Workshop A
10:00 - 13:00
How to build a biobank
This workshop will help you set up your biobank through pointing out the core functional processes and how to pilot them,
and preventing you from current difficulties.
It will notably afford you answers and guidelines to these questions:

Marie-Noelle Ungeheuer,
Clinical Investigation
and Biological
Resources Access,
Pasteur Institute, France


Workshop B
10:00 - 13:00
Why a biobank and which sort of biobank do you intend to built? – The workshop will help you define the needs of
end-users, the objectives of your biobank, the themes covered
What are the crucial processes to set up? – We will discuss how to set up core functional processes (how to draw the
flow chart for management of samples and their associated bioclinical data) but also how to pilot them, and it will
review all important support processes – Technical, ethical / regulatory, organisational, transport, etc.
Which means will you need to develop your activity? – Answers will deal with: staff and training, facilities, equipment,
IT system, quality management system
Building a non-clinical biorepository
Setting up a biorepository to document and store biological material in an organised and easily accessible manner is an
essential component for any laboratory or research institution. Getting started is a daunting exercise. The objective of this
workshop will be to discuss the preliminary steps for setting up a biosample repository.
Ashley E. Hayes,
Roche Non-Clinical
Biorepository (RNCB),
F. Hoffmann-La Roche
Ltd, Switzerland
Workshop C
14:00 - 17:00
Topics to be discussed will be the following:
 Define the specimens to be organized. Get group or management support. Look to the future and not at the past.
Consider organizational behaviour and requirements. Strive for simplicity and accuracy
 Look at specimen data collection, organizing data sets (minimum/maximum) and data processing. Consider the need
to define structure and standardization for nomenclature, controlled vocabularies, synonyms and abbreviations.
Software application, data display and Indexing
 Specimen collection, processing and storage. Authentication, quality control, biosafety and legal issues
 Specimen containers, labelling and tracking
 Building customer/user confidence and support
Inter-operability, data and sample sharing and consent convenor
This workshop will provide an opportunity to discuss issues arising from the need for biobanks to collaborate if they are
to deliver insights into common complex diseases and to provide a resource for the development of novel interventions
in a reasonable timescale.
In addition to specifically technical or administrative questions – How are samples stored, and how and what personal
data is recorded for example – Governance frameworks for biobanks will need to be aligned if they are to permit the
possibility of data and sample sharing and facilitate collaborative working between biobanks. This will be particularly
important when national boundaries are involved. Whilst national legislation and the policies and requirements of host
institutions/organisations will clearly be major factors in constraining or creating possibilities for joint working, the
governance arrangements created by biobanks themselves will also be significant contributors and/or facilitators.
Alastair Kent,
Director,
Genetic Interest
Group, UK
Amongst the issues which may be addressed are:
 Access to samples and data (who, for which purpose and under what circumstances)
 Material transfer arrangements
 Consent for use for sample donors
 Return of results (to originating biobanks and to sample donors)
 Ethics and governance structures
Workshop D
14:00 - 17:00
Biobanks and biomarkers
Prof. Dr. Gerd Schmitz,
Institute for Clinical
Chemistry and
Laboratory Medicine,
University Hospital
Regensburg, Germany
The expansion of technologies and information based medicine open new avenues to generate actionable health information.
The combination of new life imaging biomarkers, in vitro biomarkers and modern IT-based integrated biobanking strategies
will drive curative and preventive medicine innovations towards personalized medicine. Phenotypic or functional analysis of
plasma components blood cells (cytomics) and tissues will provide new high content information for disease stratification,
outcome monitoring and identification of novel biomarkers. Automated magnetic bead-based techniques allow rapid cell
isolation from blood, bone marrow and other sources of cells in suspension. The complete workflow integration of all elements
and the level of automation are still at an early stage of development. Robotised biobanking and cryoengineering, as well
as all preanalytical steps, including preservation of samples and automation of sample processing, are key elements of
HT-biobanking as a prerequisite for biomarker identification and validation.






To Register
|
Healthcare Integrated Biobanking (HIB) and epidemiologic/population-based genomic biobanking require distinct strategies
Body fluid or tissue dominated disease-specific biobanks for diagnostic, therapeutic or clinical research
Automation of preanalytics and tissue, cell and body fluid phenotyping for HT-biomarker development and adaptation of
post-banking analysis into HT-formats.
Workflow integration of HT-body fluid, cytomic and tissue biobanks and HT-analytical platforms for biomarker development
Multicenter biomarker validation towards surrogate biomarkers
Data management and process control in biobanks and biomarker development
T +49 (0)30 20 91 33 30
|
F +49 (0)30 20 91 33 12
|
E [email protected]
|
Visit www.iqpc.com/de/biobanking/MM
Biobanking &
Sample Management
Congress days
26th - 27th May 2009
Workshop day
28th May 2009
Steigenberger Airport Hotel, Frankfurt/Main, Germany
If undeliverable, please return to:
IQPC GmbH | Friedrichstraße 94 | D-10117 Berlin, Germany

Advantages and disandvantages of local
versus centralized sample processing to
capitalize on the most feasible approach

Enhance the benefits of biobanking by
sharing bioressources

Explore how to realize access to human
samples for pharma research while creating
a win-win situation for clinician and patient
Booking Code
CF
4 Ways to Register
your details: Please contact our Database Manager ([email protected]) and inform them of any incorrect
details which will be amended accordingly
Congress Packages
Early Bird
(Book and pay by the 20th February 2009)
Standard Price
Platinum Package
Save € 270,-
€ 2.429,- +VAT
€ 2.699,- + VAT
Gold Package
Save € 240,-
€ 2.159,- +VAT
€ 2.399,- + VAT
Bronze Package
2 day Congress
€ 1.999,- + VAT
Workshop Day
€ 1.199,- + VAT
2 day Congress plus 1 Workshop Day
2 day Congress plus 1/2 Workshop Day
50% Discount
for Academics
Venue and Accommodation
Steigenberger Airport Hotel
Unterschweinstiege 16
D-60549 Frankfurt am Main, Germany
Tel.: +49 (0)69 6975-0
Fax: +49 (0)69 6975-2505
www.airporthotel.steigenberger.de
Accommodation: A limited number of reduced rate rooms
are available at the congress hotel. Accommodation can be
booked by calling the central reservation number.
Please always quote the booking reference IQPC-Berlin.
Hotel accommodation and travel costs are not included
in the registration fee.
Please indicate choice of workshop on Thursday, 28th May 2009
Workshop A
|
Workshop B
|
Workshop C
|
Workshop D
Workshop A | How to build a biobank
Workshop B | Building a non-clinical biorepository
Workshop C | Inter-operability, data and sample sharing and consent convenor
Workshop D | Biobanks and biomarkers
Only one discount applicable per person. The VAT of 19% is not included in the prices above.

CAN'T MAKE IT TO THE Congress? PURCHASE THE 2-DAY Congress DOCUMENTATION ON CD-ROM
CD-ROM € 595,- +VAT
Delegate Details
Mr
Mrs
Family Name
First Name
Position
Email
Telephone
Fax
Ms
Dr
Team Discounts: Groups of 3 or more bookings at the same
time from the same company: add another 5% per person
on any Early Bird, 10% per person on standard price.
(Only for platinium/gold packages)
Payment Terms
Organisation
Payment is required by return.
Address
Cancellations and Substitutions
Postcode/Town
Signature
I agree to IQPC Gesellschaft für Management Konferenzen mbH payment terms.
Yes, I would like to receive information about products and services via email.
Payment Methods
Pay by BANK transfer quoting reference DE 17132.001:
IQPC Gesellschaft für Management Konferenzen mbH,
HSBC Trinkaus & Burkhardt AG, BLZ 300 308 80, Konto-Nr. 430076019
IBAN: DE32 30030880 0430076019, SWIFT-BIC: TUBDDEDD
By Credit Card: Please debit my credit card
Card No
Congress code DE17132.001
Team Discounts
Please fill out in Capitals!
DELEGATE
Fax:
+49 (0) 30 20 91 33 12
Post:
IQPC Gesellschaft für
Management Konferenzen mbH
Friedrichstraße 94
D-10117 Berlin, Germany
Online:
www.iqpc.com/de/biobanking/MM
Email: [email protected]
For further information
Phone:
+49 (0) 30 20 91 33 30
Expiry date
/
Cardholder’s name
Signature
Card billing address (if different from Company address)
CANCELLATIONS AND SUBSTITUTIONS
Delegates may be substituted at any time. IQPC Gesellschaft für
Management Konferenzen mbH does not provide refunds for cancellations. However, save where written notice of cancellation is
received more than seven (7) days prior to the Congress, a credit
to the value paid at that date will be issued, which may be used
against another IQPC GmbH Congress for up to one year from
its date of issue. For cancellations received seven (7) days or less
prior to an event (including day seven), no credit will be issued. In
the event that IQPC GmbH cancels an event, payments received
at the cancellation date will be credited towards attendance at
a future IQPC GmbH Congress or, in the event of a postponement
by IQPC GmbH, a rescheduled date. If the delegate is unable to
attend the rescheduled event, the delegate will receive a credit
in lieu of payments made towards a future IQPC GmbH event, valid
for one year from the date of issue. IQPC GmbH is not responsible
for any Loss or damage as a result of a substitution, alteration,
postponement or cancellation of an event due to causes beyond
its control including, without limitation, natural disasters,
sabotage, accident, trade or industrial disputes or hostilities.
your details
Please contact our Customer Service Manager (tel: +49 (0)30 20913330
or [email protected]) and inform them of any incorrect details
which will be amended accordingly or if you prefer not to get
information per Fax Email or phone anymore.
SPEAKER CHANGES
Occasionally it is necessary for reasons beyond our control to
alter the contents and timing of the programme or the identity
of the speakers.
DATA PROTECTION
Personal data is gathered in accordance with the Data Protection
Act 1998. Your details may be passed to other companies who wish
to communicate with you offers related to your business activities. If you do not wish to receive these offers, please tick the box
below.
Please do not pass my information to any third party.
By Cheque: Made payable to IQPC Gesellschaft für Management Konferenzen mbH
© IQPC Gesellschaft für Management Konferenzen mbH